{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T04:35:11Z","timestamp":1783226111456,"version":"3.54.6"},"reference-count":32,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalradiologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Radiology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.crad.2018.07.095","type":"journal-article","created":{"date-parts":[[2018,8,4]],"date-time":"2018-08-04T01:30:11Z","timestamp":1533346211000},"page":"983.e7-983.e14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Prognostic value of late gadolinium enhancement on CMR in patients with severe aortic valve disease: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"73","author":[{"given":"H.","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9540","key":"10.1016\/j.crad.2018.07.095_bib1","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(06)69208-8","article-title":"Burden of valvular heart diseases: a population-based study","volume":"368","author":"Nkomo","year":"2006","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.crad.2018.07.095_bib2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1161\/CIRCRESAHA.113.300156","article-title":"Introduction to aortic stenosis","volume":"113","author":"Carabello","year":"2013","journal-title":"Circ Res"},{"issue":"7","key":"10.1016\/j.crad.2018.07.095_bib3","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1161\/01.CIR.0000051865.66123.B7","article-title":"Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms","volume":"107","author":"Hein","year":"2003","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.crad.2018.07.095_bib4","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1161\/CIRCULATIONAHA.104.516963","article-title":"Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart","volume":"112","author":"Heymans","year":"2005","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.crad.2018.07.095_bib5","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1161\/01.CIR.91.9.2353","article-title":"Normalization of diastolic dysfunction in aortic stenosis late after valve replacement","volume":"91","author":"Villari","year":"1995","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.crad.2018.07.095_bib6","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1161\/CIRCULATIONAHA.109.924167","article-title":"Comparative evaluation of left and right ventricular endomyocardial biopsy: differences in complication rate and diagnostic performance","volume":"122","author":"Yilmaz","year":"2010","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.crad.2018.07.095_bib7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/nrcardio.2014.159","article-title":"Cardiac MRI: a central prognostic tool in myocardial fibrosis","volume":"12","author":"Ambale-Venkatesh","year":"2015","journal-title":"Nat Rev Cardiol"},{"issue":"10","key":"10.1016\/j.crad.2018.07.095_bib8","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1136\/hrt.2005.079392","article-title":"Delayed hyperenhancement in magnetic resonance imaging of left ventricular hypertrophy caused by aortic stenosis and hypertrophic cardiomyopathy: visualisation of focal fibrosis","volume":"92","author":"Debl","year":"2006","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.crad.2018.07.095_bib9","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jacc.2008.08.064","article-title":"Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling","volume":"53","author":"Rudolph","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.crad.2018.07.095_bib10","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.jacc.2011.03.064","article-title":"Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis","volume":"58","author":"Dweck","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.crad.2018.07.095_bib11","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jacc.2014.02.612","article-title":"Prognostic significance of LGE by CMR in aortic stenosis patients undergoing valve replacement","volume":"64","author":"Barone-Rochette","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.crad.2018.07.095_bib12","unstructured":"GA Wells BShea, D O'Connell, et\u00a0al. Ottawa Hospital Research Institution. The Newcastle\u2013Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at: http:\/\/www.Ohri.Ca\/programs\/clinical_epidemiology\/oxford.Asp. [Accessed 04.03.14]."},{"issue":"11","key":"10.1016\/j.crad.2018.07.095_bib13","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"issue":"3","key":"10.1016\/j.crad.2018.07.095_bib14","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trial"},{"key":"10.1016\/j.crad.2018.07.095_bib15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.pu.09.050188.001011","article-title":"A general overview of Mantel\u2013Haenszel methods: applications and recent developments","volume":"9","author":"Kuritz","year":"1988","journal-title":"Ann Rev Public Health"},{"issue":"4","key":"10.1016\/j.crad.2018.07.095_bib16","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jacc.2009.12.074","article-title":"Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease","volume":"56","author":"Azevedo","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.crad.2018.07.095_bib17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/icvts\/ivs098","article-title":"Late gadolinium enhancement as a potential marker of increased perioperative risk in aortic valve replacement","volume":"15","author":"Quarto","year":"2012","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"11","key":"10.1016\/j.crad.2018.07.095_bib18","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.jcmg.2016.10.007","article-title":"Myocardial fibrosis and cardiac decompensation in aortic stenosis","volume":"10","author":"Chin","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"issue":"6","key":"10.1016\/j.crad.2018.07.095_bib19","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.ihj.2017.05.027","article-title":"Prevalence and prognostic significance of left ventricular myocardial late gadolinium enhancement in severe aortic stenosis","volume":"69","author":"Rajesh","year":"2017","journal-title":"Indian Heart J"},{"issue":"1","key":"10.1016\/j.crad.2018.07.095_bib20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0895-4356(94)00106-Z","article-title":"Cumulative meta-analysis of clinical trials builds evidence for exemplary medical care","volume":"48","author":"Lau","year":"1995","journal-title":"J Clin Epidemiol"},{"issue":"20","key":"10.1016\/j.crad.2018.07.095_bib21","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1002\/sim.2380","article-title":"A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints","volume":"25","author":"Harbord","year":"2006","journal-title":"Stat Med"},{"issue":"10","key":"10.1016\/j.crad.2018.07.095_bib22","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/ehjci\/jes102","article-title":"Diffuse myocardial fibrosis in severe aortic stenosis: an equilibrium contrast cardiovascular magnetic resonance study","volume":"13","author":"Flett","year":"2012","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.crad.2018.07.095_bib23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10554-017-1195-y","article-title":"Cardiovascular magnetic resonance imaging to assess myocardial fibrosis in valvular heart disease","volume":"34","author":"Podlesnikar","year":"2018","journal-title":"Int J Cardiovasc Imaging"},{"issue":"5","key":"10.1016\/j.crad.2018.07.095_bib24","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.2214\/ajr.184.5.01841420","article-title":"Myocardial late enhancement in contrast-enhanced cardiac MRI: distinction between infarction scar and non-infarction-related disease","volume":"184","author":"Hunold","year":"2005","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"10.1016\/j.crad.2018.07.095_bib25","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jacc.2011.02.059","article-title":"Low-gradient aortic valve stenosis myocardial fibrosis and its influence on function and outcome","volume":"58","author":"Herrmann","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.crad.2018.07.095_bib26","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/eurheartj\/ehx353","article-title":"Reappraising myocardial fibrosis in severe aortic stenosis: an invasive and non-invasive study in 133 patients","volume":"39","author":"Treibel","year":"2018","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.crad.2018.07.095_bib27","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1161\/CIRCULATIONAHA.108.847772","article-title":"Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis","volume":"120","author":"Weidemann","year":"2009","journal-title":"Circulation"},{"issue":"38","key":"10.1016\/j.crad.2018.07.095_bib28","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/eurheartj\/ehx350","article-title":"Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement","volume":"38","author":"Castano","year":"2017","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.crad.2018.07.095_bib29","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jacc.2017.11.037","article-title":"Prevalence of cardiac amyloidosis in patients referred for transcatheter aortic valve replacement","volume":"71","author":"Scully","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.crad.2018.07.095_bib30","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005066","article-title":"Occult transthyretin cardiac amyloid in severe calcific aortic stenosis: prevalence and prognosis in patients undergoing surgical aortic valve replacement","volume":"9","author":"Treibel","year":"2016","journal-title":"Circ Cardiovas Imaging"},{"issue":"2","key":"10.1016\/j.crad.2018.07.095_bib31","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10741-014-9462-7","article-title":"Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs","volume":"20","author":"Castano","year":"2015","journal-title":"Heart Fail Rev"},{"issue":"7","key":"10.1016\/j.crad.2018.07.095_bib32","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.jcmg.2017.09.005","article-title":"Noncontrast Myocardial T1 Mapping by Cardiac Magnetic Resonance Predicts Outcome in Patients With Aortic Stenosis","volume":"11","author":"Lee","year":"2018","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["Clinical Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926018303659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926018303659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T16:38:13Z","timestamp":1757867893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009926018303659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0009926018303659"],"URL":"https:\/\/doi.org\/10.1016\/j.crad.2018.07.095","relation":{},"ISSN":["0009-9260"],"issn-type":[{"value":"0009-9260","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value of late gadolinium enhancement on CMR in patients with severe aortic valve disease: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crad.2018.07.095","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}